Stay updated on DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Sign up to get notified when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.

Latest updates to the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check25 days agoChange DetectedThe page has removed a citation for a study on Ripretinib in patients with advanced gastrointestinal stromal tumors, which included an erratum reference.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has been updated to include the term 'Gastrointestinal Stromal Tumors' and the study identifier 'DCC-2618-03-001', while the previous version's detailed study description and inclusion/exclusion criteria have been removed. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference32%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.